Skip to content

Bridging the Gap Between CBD Science and Regulation

In 2018, CBD sales in the United States were estimated at $534 million, according to the Hemp Business Journal. USA projections in 2025 are expected to reach an estimated $25 Billion. To many, CBD offers a variety of benefits when ingested, inhaled, or applied topically – with product marketing and advertising claims similarly ranging from calming effects to pain relief. Asa Waldstein joins the Atlantia team to discuss how to use clinical data for marketing purposes to overcome regulatory hurdles that many CBD companies are encountering when commercializing their innovations.

Duration: 42 mins

Webinar Highlights

Topics discussed

  • Clinical trial process and types
  • CBD research market overview
  • FDA warning letter enforcement update
  • How to use clinical data in marketing


Ted Dinan

Ted Dinan

Top cited scientist in the gut-brain axis, over 400 papers published in neurobiology.

Medical Director
Atlantia Clinical Trials

Sign Up to watch:

Panel Discussion: Bridging the gap between CBD science and regulation